NLRP3 and colitis: Research has shown that inhibition of p38 plays a protective role in many inflammatory disease models, including Parkinson’s disease, acute lung injury, colitis, and diabetic nephropathy, by regulating the activation of NLRP3 inflammasome [54,55,56,57].